Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia
Experimental Brain Research · 2024
DOI: 10.1007/s00221-024-06801-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Brain Research, 2024. Verfasst von Alexandre Seillier. Beteiligte Einrichtung: Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. alexandre.seillier@nudz.cz. Hauptthemen laut MEDLINE: Amidohydrolases, Benzamides, Carbamates, Phencyclidine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: NIH HHS, MH CZ – DRO, U.S. Public Health Service.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. alexandre.seillier@nudz.cz.
- Schizophrenia Models for Advancing Research and Treatment, Preclinical Research Program, National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic. alexandre.seillier@nudz.cz.
Förderung
- NIH HHS
- MH CZ – DRO
- U.S. Public Health Service
- National Institutes of Health
Zitieren
APA
Seillier, A. (2024). Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia. Experimental Brain Research. https://doi.org/10.1007/s00221-024-06801-2
Vancouver
Seillier A. Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia. Experimental Brain Research. 2024. doi:10.1007/s00221-024-06801-2
BibTeX
@article{Seillier2024,
author = {Seillier, Alexandre},
title = {Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia},
journal = {Experimental Brain Research},
year = {2024},
doi = {10.1007/s00221-024-06801-2}
}
EUVIMED